Brian Gazzard

1.3k citations

37 papers · 797 indexed · h-index 15

Co-authors: Nathan Clumeck Andrew Miles C Wastell M Johnson Schlomo Staszewski Christopher Stone Sarah Moore Willy Rozenbaum
Topics: HIV Research and Treatment (17 papers)HIV/AIDS drug development and treatment (17 papers)HIV-related health complications and treatments (12 papers)
Cited by: Virology Infectious Diseases Emergency Medicine
Journals: Journal of Clinical Oncology Circulation Research The British Journal of Psychiatry
Partner nations: United Kingdom United States France

In The Last Decade

Brian Gazzard

35 papers receiving 744 citations

Peers

Countries citing papers authored by Brian Gazzard

Since Specialization

Citations

This map shows the geographic impact of Brian Gazzard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Gazzard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Gazzard more than expected).

Fields of papers citing papers by Brian Gazzard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Gazzard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Gazzard. The network helps show where Brian Gazzard may publish in the future.

Co-authorship network of co-authors of Brian Gazzard

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Gazzard. A scholar is included among the top collaborators of Brian Gazzard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Gazzard. Brian Gazzard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long‐term efficacy and safety of E/C/F/TDF vs EFV/FTC/TDF and ATV+RTV+FTC/TDF in HIV‐1‐infected treatment‐naïve subjects ≥50 years 2014 ·Journal of the International AIDS Society ·Brian Gazzard,Pierre Marie Girard,Giovanni Di Perri,Joel E. Gallant,William Towner,(unknown),(unknown),Damian J. McColl,Hui Liu,Martin S. Rhee,Javier Szwarcberg,David Piontkowsky	2
2	Efficacy of switching to rilpivirine/emtricitabine/tenofovir DF from boosted PI in HIV-1 virologically suppressed patients with or without the K103N 2013 ·Journal of the International AIDS Society ·(unknown),Pablo Tebas,Martin Fisher,Brian Gazzard,(unknown),Jan van Lunzen,David Shamblaw,Jason Flamm,Ramin Ebrahimi,Danielle Porter,(unknown),Shampa De-Oertel,Todd Fralich,Romina Quercia	2
3	Maintaining cost-effective access to antiretroviral drug therapy through a collaborative approach to drug procurement, consensus treatment guidelines and regular audit: the experience of London HIV commissioners and providers 2012 ·Sexually Transmitted Infections ·(unknown),Brian Gazzard,Margaret Johnson,(unknown),Simon Collins	8
4	Models for palliative care in sub-Saharan Africa 2010 ·International Health ·(unknown),Brian Gazzard	2
5	Investigation of low-dose ritonavir on human peripheral blood mononuclear cells using gene expression whole genome microarrays 2010 ·Genomics ·Saliha Yılmaz,Marta Boffito,Sophie Collot-Teixeira,(unknown),Laura Waters,(unknown),David Back,Anton Pozniak,Brian Gazzard,(unknown)	8
6	Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention? United Kingdom Collaborative HIV Cohort Study Group 2009 ·UCL Discovery (University College London) ·(unknown),Clifford Leen,Jonathan Ainsworth,J. Anderson,(unknown),Philippa Easterbrook,Michael T. Fisher,Brian Gazzard,Richard Gilson,Mark Gompels,Tetiana Hill,(unknown),Chloe Orkin,AN Phillips,Kholoud Porter,Frank Post,John Walsh,Caroline Sabin,(unknown)	7
7	CD4 counts and the risk of systemic non-Hodgkin's lymphoma in individuals with HIV in the UK 2009 ·Haematologica ·Mark Bower,Martin Fisher,Tetiana Hill,Iain Reeves,John J. Walsh,Chloe Orkin,Andrew Phillips,(unknown),Richard Gilson,Philippa Easterbrook,Margaret Johnson,Brian Gazzard,Clifford Leen,Deenan Pillay,Achim Schwenk,Jane Anderson,Kholoud Porter,Mark Gompels,Caroline Sabin	45
8	A phase I, randomized study of combined IL-2 and therapeutic immunisation with antiretroviral therapy 2007 ·PubMed ·Gareth Hardy,Nesrina Imami,Mark Nelson,Ann Sullivan,(unknown),Marlén M. I. Aasa-Chapman,Brian Gazzard,Frances Gotch	19
9	Immunodeficiency and the gut 2007 ·Medicine ·Brian Gazzard	0
10	Effect of omeprazole on the pharmacokinetics of saquinavir-500 mg formulation with ritonavir in healthy male and female volunteers 2006 ·AIDS ·Alan Winston,David Back,(unknown),(unknown),(unknown),(unknown),Malte Schütz,Anton Pozniak,Brian Gazzard,Marta Boffito	38
11	Effects of nandrolone decanoate compared with placebo or testosterone on HIV‐associated wasting 2006 ·HIV Medicine ·Julian Gold,Marijka Batterham,Hans Rekers,(unknown),T. B. Paul Geurts,(unknown),(unknown),(unknown),George Panos,Aldo Pinchera,F Aiuti,(unknown),Andrzej Horban,(unknown),Praphan Phanuphak,Wisit Prasithsirikul,Brian Gazzard,Miki Bloch,(unknown)	39
12	TRIZAL study: switching from successful HAART to Trizivir^TM (abacavir‐lamivudine‐zidovudine combination tablet): 48 weeks efficacy, safety and adherence results 2003 ·HIV Medicine ·Christine Katlama,(unknown),Brian Gazzard,Adriano Lazzarin,Nathan Clumeck,Josep Mallolas,Alain Lafeuillade,(unknown),(unknown)	66
13	Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA 2001 ·AIDS ·Nathan Clumeck,F. D. Goebel,Willy Rozenbaum,Jan Gerstoft,Schlomo Staszewski,(unknown),M Johnson,Brian Gazzard,Christopher Stone,(unknown),Sarah Moore	117
14	Investigation and control of a large outbreak of multi-drug resistant tuberculosis at a central Lisbon hospital 2001 ·Journal of Hospital Infection ·Margaret M. Hannan,(unknown),Fernando Maltêz,Andrew Hayward,(unknown),(unknown),Rui Proença,M Nelson,(unknown),D B Young,Brian Gazzard	32
15	Testing patients for HIV before surgery: The views of doctors performing surgery 1995 ·AIDS Care ·Kate Chapman,(unknown),José Catalán,Brian Gazzard	6
16	Eating Disorders in Men with HIV Infection 1992 ·The British Journal of Psychiatry ·(unknown),José Catalán,Brian Gazzard	16
17	Preclinical and clinical studies on immunogenicity and safety of the HIV-1 p17-based synthetic peptide AIDS vaccine — HGP-30-KLH 1991 ·International Journal of Immunopharmacology ·Paul H. Naylor,Marcelo B. Sztein,(unknown),Scott H. Maurer,Daniel A. Holterman,Janet E. Kirkley,(unknown),Bernard C. Zook,(unknown),Clarence J. Gibbs,Daniel Zagury,Ammar Achour,Carol O’Toole,Brian Gazzard,Mike Youle,(unknown),Prem S. Sarin,Allan L. Goldstein	24
18	The value of serum cryptococcal antigen in the diagnosis of cryptococcal infection in patients infected with the human immunodeficiency virus 1990 ·Journal of Infection ·M Nelson,Mark Bower,Don Smith,(unknown),D.C. Shanson,Brian Gazzard	27
19	Treatment of acquired immune deficiency syndrome (AIDS)related pneumonitis with foscarnet: A double-blind placebo controlled study 1990 ·Journal of Infection ·M Youle,A. C. Chañas,Brian Gazzard	7
20	The efficacy and toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex (ARC): an open uncontrolled treatment study. 1989 ·PubMed ·(unknown),M Youle,David Hawkins,Charles Farthing,D.C. Shanson,Richard Farmer,Adam G. Lawrence,Brian Gazzard	19

About Brian Gazzard

Brian Gazzard is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 37 papers that have together received 797 indexed citations. Recurring topics across this work include HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (17 papers) and HIV-related health complications and treatments (12 papers). The work is most often cited by research in Virology (337 citations), Infectious Diseases (480 citations) and Emergency Medicine (189 citations). Brian Gazzard has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Nathan Clumeck, Andrew Miles, C Wastell, M Johnson, Schlomo Staszewski, Christopher Stone, Sarah Moore, Willy Rozenbaum, F. D. Goebel and Jan Gerstoft. Their work appears in journals such as Journal of Clinical Oncology, Circulation Research and The British Journal of Psychiatry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact